SGEN. climber. PR. $30.30 A biotechnology company
Post# of 63699
SGEN. climber. PR. $30.30
A biotechnology company focused on
antibody-based therapies for the treatment of cancer.
SGEN. climber. PR. $30.30
A biotechnology company focused on
antibody-based therapies for the treatment of cancer.